Hemophilia A and B: molecular and clinical similarities and differences

被引：112
作者：
Castaman, Giancarlo [1 ]
Matino, Davide [2 ,3 ]
机构：
[1] Careggi Univ Hosp, Ctr Bleeding Disorders & Coagulat, Dept Oncol, Florence, Italy
[2] McMaster Univ, Dept Med, Hamilton, ON, Canada
[3] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada
来源：
HAEMATOLOGICA | 2019年 / 104卷 / 09期
关键词：
FC FUSION PROTEIN; V-LEIDEN MUTATION; FACTOR-IX; FACTOR-VIII; BLEEDING PHENOTYPE; IMMUNE TOLERANCE; LESS SEVERE; RISK; SEVERITY; BINDING;
D O I：
10.3324/haematol.2019.221093
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1702 / 1709
页数：8
相关论文
共 54 条
  • [1] Rituximab and desensitization for a patient with severe factor IX deficiency, inhibitors, and history of anaphylaxis
    Alexander, Sarah
    Hopewell, Steve
    Hunter, Susan
    Chouksey, Akhilesh
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2008, 30 (01) : 93 - 95
  • [2] The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIII
    Amano, K
    Sarkar, R
    Pemberton, S
    Kemball-Cook, G
    Kazazian, HH
    Kaufman, RJ
    [J]. BLOOD, 1998, 91 (02) : 538 - 548
  • [3] ARBINI AA, 1995, THROMB HAEMOSTASIS, V74, P1255
  • [4] Belvini D, 2005, HAEMATOLOGICA, V90, P635
  • [5] Modern haemophilia care
    Berntorp, Erik
    Shapiro, Amy D.
    [J]. LANCET, 2012, 379 (9824) : 1447 - 1456
  • [6] The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey
    Biss, T. T.
    Chan, A. K.
    Blanchette, V. S.
    Iwenofu, L. N.
    Mclimont, M.
    Carcao, M. D.
    [J]. HAEMOPHILIA, 2008, 14 (05) : 923 - 930
  • [7] Definitions in hemophilia: communication from the SSC of the ISTH
    Blanchette, V. S.
    Key, N. S.
    Ljung, L. R.
    Manco-Johnson, M. J.
    Van Den Berg, H. M.
    Srivastava, A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (11) : 1935 - 1939
  • [8] Haemophilias A and B
    Bolton-Maggs, PHB
    Pasi, KJ
    [J]. LANCET, 2003, 361 (9371) : 1801 - 1809
  • [9] Brummel-Ziedins KE, 2014, TXB HAEMOPHILIA, P1
  • [10] Molecular and clinical predictors of inhibitor risk and its prevention and treatment in mild hemophilia A
    Castaman, Giancarlo
    Fijnvandraat, Karin
    [J]. BLOOD, 2014, 124 (15) : 2333 - 2336
123456